Brief: Arterra Bioscience Signs Supply, Licence Deal With ADL Farmaceutici
April 8 (Reuters) - Arterra Bioscience SpA ABIS.MI :
* SAID ON WEDNESDAY IT HAD SIGNED DEAL WITH ADL FARMACEUTICI
FOR
SUPPLY AND LICENSE TO USE TRADEMARK OF OWN EXCLUSIVE OWNERSHIP
* DEAL HAS 5-YEAR DURATION
* ADL FARMACEUTICI COMPANY IS ACTIVE IN NUTRACEUTICALS AND
MEDICAL
DEVICES SECTOR
Source text for Eikon: urn:newsml:reuters.com:*:nBIA7Fz5yj
Further company coverage: ABIS.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Arterra Bioscience SpA
See all newsBrief: Arterra Bioscience - Q1 Revenue EUR 1.6 Million
Brief: Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
Brief: Arterra Bioscience FY Net Profit EUR 2.0 Mln
Brief: Arterra Bioscience FY Revenue At EUR 4.6 Mln
Brief: Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital